These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epsilon-aminocaproic acid myopathy. Report of a case and literature review. Vanneste JA; van Wijngaarden GK Eur Neurol; 1982; 21(4):242-8. PubMed ID: 7117311 [TBL] [Abstract][Full Text] [Related]
3. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. MacKay AR; Sang U H; Weinstein PR J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689 [TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Britt CW; Light RR; Peters BH; Schochet SS Arch Neurol; 1980 Mar; 37(3):187-8. PubMed ID: 7356431 [TBL] [Abstract][Full Text] [Related]
5. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review. Galassi G; Gibertoni M; Corradini L; Colombo A Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249 [TBL] [Abstract][Full Text] [Related]
6. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report. Tubbs RR; Benjamin SP; Dohn DE J Neurosurg; 1979 Jul; 51(1):94-7. PubMed ID: 448423 [TBL] [Abstract][Full Text] [Related]
7. Myopathy induced by epsilon-aminocaproic acid. Case report. Brown JA; Wollmann RL; Mullan S J Neurosurg; 1982 Jul; 57(1):130-4. PubMed ID: 7086489 [TBL] [Abstract][Full Text] [Related]
8. Epsilon-aminocaproic acid-induced myopathy. A case report. Morris CD; Jacobs P; Berman PA; Rutherfoord GS S Afr Med J; 1983 Sep; 64(10):363-6. PubMed ID: 6612533 [TBL] [Abstract][Full Text] [Related]
9. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial. Shucart WA; Hussain SK; Cooper PR J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206 [TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition. Burchiel KJ; Hoffman JM; Bakay RA Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999 [TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis. Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982 [TBL] [Abstract][Full Text] [Related]
12. Epsilon aminocaproic acid (EACA) myopathy. Lane RJ; McLelland NJ; Martin AM; Mastaglia FL Postgrad Med J; 1979; 55(642):282-5. PubMed ID: 471867 [TBL] [Abstract][Full Text] [Related]
13. Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage. Chowdhary UM; Sayed K J Neurol Neurosurg Psychiatry; 1981 Sep; 44(9):810-3. PubMed ID: 7031186 [TBL] [Abstract][Full Text] [Related]